Top Markets
#1 EXOD EXOD +22.08%
#2 Ontology Gas Ontology Gas +19.28%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +17.82%
#4 Geodnet Geodnet +17.14%
#5 Derive Derive +16.24%
#6 Neiro Neiro +14.58%
#7 Status Status +13.58%
#8 Pons Pons +12.49%
#9 Ergo Ergo +11.89%
#10 Collect on Fanable Collect on Fanable +10.15%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Apollomics, Inc. Apollomics, Inc.

Apollomics, Inc.

APLM
Clasificación en acciones #25238
Apollomics, Inc., a biotechnology enterprise established in 2015 and... Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, China, and Australia. The company is dedicated to discovering and advancing innovative oncology treatments to address critical unmet medical requirements. Its therapeutic pipeline features APL-101 (Vebreltinib), a potent and selective c-Met inhibitor being developed for non-small cell lung cancer and other advanced malignancies. Also in development is APL-102, an orally administered, small molecule multiple tyrosine kinase inhibitor intended for liver, breast, and esophageal cancers. Furthermore, APL-122 is an investigational tumor inhibitor candidate focused on treating cancers within the brain. The organization was formerly known as CBT Pharmaceuticals, Inc. before adopting the name Apollomics, Inc. in January 2019.
Precio por acción
$23.57
Última sincronización: 2026-08-20
Capitalización bursátil
$51.76M
Cambio (1 día)
-0.08%
Cambio (1 año)
289.59%
País
US
Comercio Apollomics, Inc. (APLM)

Categoría

Healthcare
EPS de Apollomics, Inc. (APLM)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Apollomics, Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Apollomics, Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US